...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >COST-EFFECTIVENESS OF FIRST-LINE S-1 THERAPY FOR METASTATIC BREAST CANCER PATIENTS COMPARED WITH TAXANES: AN ANALYSIS BASED ON THE RANDOMIZED PHASE III SELECT BC TRIAL

【24h】

COST-EFFECTIVENESS OF FIRST-LINE S-1 THERAPY FOR METASTATIC BREAST CANCER PATIENTS COMPARED WITH TAXANES: AN ANALYSIS BASED ON THE RANDOMIZED PHASE III SELECT BC TRIAL

机译：与TAXANES相比转移性乳腺癌患者一线S-1治疗的成本效益：基于随机化的III期选择BC试验的分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Shiroiwa T.; Fukuda T.; Shimozuma K.; Mouri M.; Hagiwara Y.; Kawahara T.; Ohsumi S.; Hozumi Y.; Sagara Y.; Ohashi Y.; Mukai H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. COST-EFFECTIVENESS OF FIRST-LINE S-1 THERAPY FOR METASTATIC BREAST CANCER PATIENTS COMPARED WITH TAXANES: AN ANALYSIS BASED ON THE RANDOMIZED PHASE III SELECT BC TRIAL [J] . Shiroiwa T., Fukuda T., Shimozuma K., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：与TAXANES相比转移性乳腺癌患者一线S-1治疗的成本效益：基于随机化的III期选择BC试验的分析
3. Responder analyses of patient-reported outcomes for evaluating the clinical significance of first-line S-1 over taxane therapy among patients with metastatic breast cancer: the open-label randomized phase III SELECT-BC trial [J] . Kawahara Takuya, Shimozuma Kojiro, Shiroiwa Takeru, Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation . 2016,第Suppla1期

机译：病人报告结果的应答者分析，用于评估转移性乳腺癌患者中一线S-1优于紫杉烷类疗法的临床意义：开放标签随机SELECT III期临床试验
4. Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial [J] . Shiroiwa T., Fukuda T., Shimozuma K., Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation . 2017,第2期

机译：由转移乳腺癌患者的EQ-5D测量的长期健康状况：在随机阶段III中的一线口服S-1和紫杉烷疗法的比较选择BC试验
5. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
6. Utilities of metastatic breast cancer patients treated with taxanes compared to utilities of oncology nurses. [D] . Hauser, Robert Sean. 2001

机译：与肿瘤科护士相比，使用紫杉烷类治疗的转移性乳腺癌患者的效用。
7. Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial [O] . T. Shiroiwa, T. Fukuda, K. Shimozuma, -1

机译：通过EQ-5D在转移性乳腺癌患者中测得的长期健康状况：在SELECT III SELECT随机试验中比较一线口服S-1和紫杉烷疗法
8. Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial [O] . 2017

机译：通过EQ-5D在转移性乳腺癌患者中测得的长期健康状况：在SELECT III SELECT随机试验中比较一线口服S-1和紫杉烷疗法

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号